|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of omlizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial 显示文摘 | Casale TB Condemi J LaForce C | 2001 | JAMA2001，286，23： | 1 |
| 2 | Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis显示文摘 | Mohar D Berger W E Laforce C | 2012 | Allergy Asthma Proc2012，33，1： | 1 |
| 3 | Use of nasal steroids in managing allergic rhinitis显示文摘 | Laforce C | 1999 | J Allergy Clin Immunol1999，103，： | 1 |
| 4 | Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study 显示文摘 | NATHAN RA FINN AF JR LAFORCE C | 2006 | Ann Allergy Asthma Immunol2006，97，3： | 1 |
| 5 | Use of nasal steroids in managing al lergic rhinitis显示文摘 | LAFORCE C | 1999 | J Allergy Clin Immunol1999，103，： | 1 |
| 6 | Use of nasal steroids in managing allergic rhinitis显示文摘 | LaForce C | 1999 | J Allergy Clin Immunol1999，103，32： | 1 |
| 7 | Effect of omali- zumab on symptoms of seasonal allergic rhinitis: a ran- domized controlled trial显示文摘 | Casale TB Condemi J LaForce C | 2001 | JAM_A2001，286，23： | 1 |
| 8 | Sustained 24-hour efficacy of once daily indacaterol(300mug)in patientswith chronic obstructive pulmonary disease: A randomized,crossover study显示文摘 | Laforce C Aunlann J de Teresa Parrefiol | 2011 | Pulm Pharmaco Ther2011，24，1： | 1 |
| 9 | Effect of omalizumab on symptoms of sea-sonal allergic rhinitis:a randomized controlled trial 显示文摘 | Casale TB Condemi J Laforce C | 2001 | Jama2001，286，： | 1 |
| 10 | Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti- interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma显示文摘 | Parker J Oh C LaForce C | 2011 | BMC Pulm Med2011，11，： | 1 |
| 11 | Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid 显示文摘 | FOWLER A MILLER C LAFORCE D | 2012 | European Resp J2012，，： | 1 |
| 12 | Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoelonal antibody, in two randomized phase 2a studies in subjects with asthma显示文摘 | Parker JM Oh CK LaForce C | 2011 | BMC Pulm Med2011，11，： | 1 |
| 13 | A randomized, doubleblind, parallel group, multieenter, placebo-controlled study of the safety and efficacy of extended release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections显示文摘 | LaForce C Gentile DA Skoner DP | 2008 | Postgrad Med2008，120，2： | 1 |
| 14 | Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528 ,a human- ized anti-interleukin-9monoclonal antibody, in two randomized phase 2a studies in subjects with asthma显示文摘 | Parker JM Oh CK LaForce C | 2011 | BMC Pulm Med2011，11，： | 1 |
| 15 | MP29-02 ( a novel intranasal formulation of aselastin hydrochloride and fluticasone propionate ) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety显示文摘 | Meltzer EO LaForce C Ratner P | 2012 | Allergy Asthma Proc2012，33，4： | 1 |
| 16 | Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528,a humanized anti-interleukin-9 monoclonal antibody,in two randomized phase 2a studies in subjects with asthma显示文摘 | PARKER J M OH C K LAFORCE C | 2011 | BMC Pulm Med2011，11，： | 1 |
| 17 | Indacaterol provides sustained 24 h bronchodilation on oncedaily dosing in asthma: a 7-day dose-ranging study 显示文摘 | LaForce C Alexander M Deckelmann R | 2008 | Allergy2008，63，1： | 1 |
| 18 | Effect of omalizumab on symptoms of seasonal aller- gicrhinitis显示文摘 | THOMAS B CONDEMIJ LAFORCE C | 2001 | JAMA2001，286，： | 1 |
| 19 | MP29-02(a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate)in the treatment of seasonal allergic rhinitis:a randomized,double-blind,place-controlled trial of efficacy and safety显示文摘 | MELTZER E O LAFORCE C RATNER P | 2012 | Allergy Asthma Proc2012，33，： | 1 |
| 20 | QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease 显示文摘 | Noord JA Buhl R LaForce C | 2010 | Thorax2010，65，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员